Latest Uk Expansion News

PEXA Group Ltd reported a robust FY25 with 16% revenue growth and a 21% rise in EBITDA, driven by national expansion and operational efficiencies. The company is advancing its UK platform launch backed by NatWest, while FY26 guidance signals continued growth and strategic focus on AI and resilience.

PEXA Group Limited reported a 16% revenue increase to $393.6 million for FY25, driven by growth across its Australian Exchange, UK International business, and Digital Solutions segments. Despite a statutory net loss of $76.1 million due to impairments and deferred tax derecognition, core EBITDA rose 21% with improved margins.

Steadfast Group reported a robust FY25 with underlying NPAT rising 17.2% to $295.5 million, driven by strong organic growth and strategic acquisitions in the US and UK. The insurer broker continues to invest in technology and international expansion while raising dividends.

Microba Life Sciences reported a 30% increase in revenue to $15.7 million for FY25, driven by strong growth in its core microbiome diagnostic products and successful UK market expansion. Despite narrowing its net loss to $14.9 million, the company is focused on scaling diagnostics adoption and achieving break-even in FY26.

Kelsian Group reported a strong FY25 with revenue up 9.5% and EBITDA growth of 7.4%, underpinned by contract renewals and operational excellence. The company also advanced key strategic initiatives including a Tourism Portfolio sale and UK expansion.

AUB Group Limited delivered a robust FY25 performance, with underlying NPAT rising 17.1% to AUD 200.2 million, driven by strategic acquisitions and margin improvements. The company’s aggressive UK retail expansion and diversified portfolio underpin a confident FY26 outlook.

Nick Scali Limited reported a resilient FY25 with solid sales growth in Australia and New Zealand, while UK operations continue to improve margins despite ongoing losses. The company declared a fully franked dividend and outlined plans for further expansion.

Nick Scali Limited reported a 5.8% revenue increase to $495.3 million in FY25, driven by its UK acquisition, but statutory net profit fell 28.4% amid integration and freight disruption costs. The company declared a fully franked final dividend of 33 cents per share.

HALO Technologies reports $3.54 million in Q2 revenue with rising subscription income, progressing UK expansion pending FCA approval, and a $6.75 million capital raise nearing completion.

PEXA’s UK arm has secured a formal commitment from NatWest to implement its digital platform for remortgage and sale & purchase transactions, marking a pivotal step in PEXA’s UK expansion.

Microba Life Sciences announces a $12.5 million equity raise, including a strategic $8.3 million investment from Sonic Healthcare, aiming to fuel growth in the UK and achieve regional break-even by FY26.

Cash Converters has secured a £12 million growth facility from Lloyds Bank and agreed to acquire 10 UK franchise stores, marking a significant step in its UK expansion strategy.